Table 3: Posthoc Analysis of coagulation activation and systemic inflammation markers of Type 2 diabetic patients in ESUTH.
|
Group |
|
MPV |
PDW |
PCT |
NLR |
PLR |
MLR |
|
T2DM |
Male vs. T2DM Female |
0.021 |
0.453 |
0.01 |
0.229 |
0.033 |
0.616 |
|
T2DM |
Male vs. Control (male) |
0.010 |
0.01 |
0.016 |
0.605 |
0.001 |
0.000 |
|
T2DM |
Male vs. Control(Female) |
0.010 |
0.001 |
0.018 |
0.594 |
0.001 |
0.000 |
|
T2DM |
Female vs. Control(male) |
0.010 |
0.001 |
0.014 |
0.110 |
0.046 |
0.016 |
|
T2DM |
Female vs. Control(Female) |
0.001 |
0.036 |
0.010 |
0.087 |
0.001 |
0.010 |
|
Male |
Control vs. Female Control |
0.055 |
0.903 |
0.989 |
0.938 |
0.010 |
0.461 |
Key: MPV: Mean Platelet Volume; PDW: Platelet Distribution Width; PCT: Plateletcrit; NLR: Neutrophil Lymphocyte Ratio; PLR: Platelet Lymphocyte Ratio; MLR: Monocyte Lymphocyte Ratio